Published in Otolaryngol Head Neck Surg on March 12, 2013
Prognostic biomarkers in thyroid cancer. Virchows Arch (2014) 0.95
Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma. Br J Cancer (2014) 0.93
Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World J Surg Oncol (2016) 0.86
Genetics and epigenetics of sporadic thyroid cancer. Mol Cell Endocrinol (2013) 0.85
The association between BRAF (V600E) mutation and pathological features in PTC. Eur Arch Otorhinolaryngol (2014) 0.84
Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model. J Surg Oncol (2016) 0.76
Association of BRAF(V600E) Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers. Thyroid (2016) 0.76
Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications. J Clin Med Res (2016) 0.75
A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma. Endocr Connect (2017) 0.75
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell (2009) 7.09
Profiling critical cancer gene mutations in clinical tumor samples. PLoS One (2009) 5.63
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol (2009) 2.94
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst (2009) 2.53
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomarkers Prev (2012) 2.13
European position paper on drug-induced sedation endoscopy (DISE). Sleep Breath (2014) 1.74
Minimally invasive nonendoscopic thyroidectomy. Otolaryngol Head Neck Surg (2006) 1.56
The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci (2006) 1.53
Differential requirement of mTOR in postmitotic tissues and tumorigenesis. Sci Signal (2009) 1.47
Identification of prostate cancer risk categories according to surgical margins status, pathological stage and Gleason score. Int J Urol (2013) 1.43
Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. Surgery (2004) 1.42
mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol (2011) 1.40
Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol (2011) 1.39
Obstructive Sleep Apnea in Adults: The Role of Upper Airway and Facial Skeletal Surgery. Plast Reconstr Surg (2017) 1.38
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol (2010) 1.37
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. Am J Pathol (2010) 1.30
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation (2004) 1.27
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells. J Pathol (2012) 1.22
Establishment and genomic characterization of mouse xenografts of human primary prostate tumors. Am J Pathol (2010) 1.15
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors. Diabetes (2004) 1.14
Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. Glycobiology (2003) 1.13
Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep (2009) 1.13
Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis (2010) 1.12
Gleason grade progression is uncommon. Cancer Res (2013) 1.09
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples. Onco Targets Ther (2013) 1.08
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis (2005) 1.06
Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids (2010) 1.06
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev (2013) 1.04
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry. J Clin Pathol (2012) 1.03
Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev (2009) 1.03
Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.03
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer. Am J Clin Pathol (2008) 1.02
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.02
Functional expansion pharyngoplasty in the treatment of obstructive sleep apnea. Laryngoscope (2013) 1.01
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. J Natl Cancer Inst (2013) 0.97
The endocannabinoid system and the treatment of obesity. Ann Med (2005) 0.97
Glucocorticoids and type 2 diabetes: from physiology to pathology. J Nutr Metab (2012) 0.96
Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol (2012) 0.96
Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease. Alcohol Alcohol (2002) 0.94
Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS. J Lipid Res (2011) 0.94
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.93
Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 0.93
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis. Biochem Biophys Res Commun (2010) 0.93
Transient hypoparathyroidism following thyroidectomy: a prospective study and multivariate analysis of 604 consecutive patients. Otolaryngol Head Neck Surg (2007) 0.93
The value of neurostimulation and intraoperative nerve monitoring of inferior laryngeal nerve in thyroid surgery. Otolaryngol Head Neck Surg (2009) 0.90
Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. Hepatology (2002) 0.89
[Pharmacological therapy of obesity]. G Ital Cardiol (Rome) (2008) 0.88
Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab (2002) 0.88
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Prostate (2015) 0.88
Primary paraganglioma strictly confined to the liver and mimicking hepatocellular carcinoma: an immunohistochemical and in situ hybridization study. Am J Surg Pathol (2002) 0.86
Accuracy of PTH assay and corrected calcium in early prediction of hypoparathyroidism after thyroid surgery. Otolaryngol Head Neck Surg (2008) 0.86
The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy. Urol Oncol (2009) 0.84
CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer. Mod Pathol (2012) 0.84
Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry. Diagn Mol Pathol (2008) 0.83
Steroids and the metabolic syndrome. J Steroid Biochem Mol Biol (2008) 0.83
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases. Curr Opin Pharmacol (2006) 0.83
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. Clin Nucl Med (2011) 0.82
Intraoperative neuromonitoring in thyroid surgery: a point prevalence survey on utilization, management, and documentation in Italy. Updates Surg (2014) 0.81
Slug/β-catenin-dependent proinflammatory phenotype in hypoxic breast cancer stem cells. Am J Pathol (2013) 0.81
β-Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis. Am J Clin Pathol (2011) 0.81
Inguinal canal tumors of adulthood. Anticancer Res (2013) 0.81
A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience. Transplantation (2004) 0.81
Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on italian high-school students. J Clin Endocrinol Metab (2013) 0.80
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. Liver Transpl (2008) 0.80
Differing risk of cancer death among patients with pathologic T3a renal cell carcinoma: identification of risk categories according to fat infiltration and renal vein thrombosis. Clin Genitourin Cancer (2013) 0.80
Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transpl Int (2008) 0.80
Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis. J Hepatol (2004) 0.79
Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings. Clin Nucl Med (2014) 0.79
Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women. J Clin Endocrinol Metab (2013) 0.79
The endocannabinoid system in the regulation of cardiometabolic risk factors. Am J Cardiol (2007) 0.79
Combined aldosterone and cortisol secretion by adrenal incidentaloma. Int J Surg Pathol (2011) 0.79
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. Virchows Arch (2011) 0.79
One-phase management of severe obstructive sleep apnea: tongue base reduction with hyoepiglottoplasty plus uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg (2006) 0.78
Quantification of free plasma DNA before and after chemotherapy in patients with advanced epithelial ovarian cancer. Diagn Mol Pathol (2008) 0.78
Anterolateral thigh free flap for tracheal reconstruction after parastomal recurrence. Head Neck (2009) 0.78
The unrelenting fall of the pharmacological treatment of obesity. Endocrine (2013) 0.78
Laryngeal neuromonitoring and neurostimulation versus neurostimulation alone in thyroid surgery: a randomized clinical trial. Head Neck (2011) 0.77
A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort. Endocrine (2011) 0.77
The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: a retrospective study. Dig Liver Dis (2013) 0.77
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. Transplantation (2008) 0.77
Cross-talk between adipose tissue and the HPA axis in obesity and overt hypercortisolemic states. Horm Mol Biol Clin Investig (2014) 0.77
Many facets of chromosome 3p cytogenetic findings in clear cell renal carcinoma: the need for agreement in assessment FISH analysis to avoid diagnostic errors. Histol Histopathol (2011) 0.77
Apoptosis in alcoholic hepatitis. J Hepatol (2002) 0.76
Feeding disorders and obesity. Curr Top Behav Neurosci (2009) 0.76
A case report on the efficacy of transverse expansion in severe obstructive sleep apnea syndrome. Sleep Breath (2008) 0.76
Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women. Horm Mol Biol Clin Investig (2015) 0.76
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. Diagn Mol Pathol (2009) 0.75
Revisiting hyper- and hypo-androgenism by tandem mass spectrometry. Rev Endocr Metab Disord (2013) 0.75
Virologic and genetic evaluation of vemurafenib-induced skin cancers. Cutan Ocul Toxicol (2014) 0.75
[Endocannabinoid system and energy metabolism: physiology and pathophysiology]. G Ital Cardiol (Rome) (2008) 0.75
The Italian multiorgan donor cancer screening protocol: 2002-2005 experience. Transplantation (2008) 0.75
A retrospective study to reduce prostate biopsy cores by a real time interactive tool. Arch Ital Urol Androl (2010) 0.75
Aldosterone and type 2 diabetes mellitus. Horm Mol Biol Clin Investig (2016) 0.75
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. Diagn Mol Pathol (2005) 0.75
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors. Anticancer Drugs (2016) 0.75
Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study. Appl Immunohistochem Mol Morphol (2016) 0.75
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation. Diagn Mol Pathol (2005) 0.75